Identification of CpG islands hypermethylated in human lung cancer by the arbitrarily primed-PCR method

Human Genetics
T KohnoJ Yokota

Abstract

DNA hypermethylation is believed to be involved in human carcinogenesis, since it suppresses the transcription of defined genes and is associated with chromosomal instability. In this study, we identified CpG islands that are hypermethylated in human lung cancer by a modified arbitrarily primed-polymerase chain reaction method using genomic DNAs digested with a methylation-sensitive restriction enzyme, HpaII, as templates. When we analyzed genomic DNAs from normal lung tissues and non-small cell lung carcinoma cell lines using three arbitrary primers, three DNA fragments were amplified from lung cancer DNAs but not from normal lung DNAs. Restriction mapping and Southern blot analysis revealed that all of these bands were amplified from CpG islands that were hypermethylated in the lung cancer cell lines. These islands were mapped to chromosomes 4q34, 10q26 and 17p13.1-p13.2, respectively, and these chromosomal regions were also hypermethylated in a subset of primary lung tumors in vivo. Thus, diverse chromosomal regions are hypermethylated in lung cancer cells. The results also indicate that this method is simple and effective for screening of CpG islands that are hypermethylated in cancer cells.

Citations

Apr 26, 2003·DNA Repair·Susan S WallaceJeffrey P Bond
May 2, 2003·Annals of the New York Academy of Sciences·Arti PatelAsad Umar
Dec 14, 1999·The Journal of Thoracic and Cardiovascular Surgery·K M FongJ D Minna
Oct 10, 2002·The Surgical Clinics of North America·Christine L LauDavid H Harpole
Mar 21, 2002·Clinics in Chest Medicine·Kwun M Fong, John D Minna
Apr 10, 1999·Electrophoresis·J M Navarro, J L Jorcano
Apr 24, 2004·Molecular Endocrinology·Adil BaharWilliam E Farrell
Sep 30, 1999·Environmental Health Perspectives·T Rao, B Richardson
Sep 6, 2014·Indian Journal of Plastic Surgery : Official Publication of the Association of Plastic Surgeons of India·Sathya Kumar DevireddyMannava Siddhartha
Sep 26, 2007·Expert Review of Molecular Diagnostics·Huidong ShiCharles W Caldwell
Apr 17, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kyong-Ah YoonJin Soo Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.